Evidence map›Paper›PMID 37850764›Full record

Observational studyActa bio-medica : Atenei Parmensis2023

The effects of excess weight on glucose homeostasis in young adult females with β-thalassemia major (β-TM): a preliminary retrospective study.

Vincenzo De Sanctis, Shahina Daar, Ashraf T Soliman, Ploutarchos Tzoulis, Mohamed Yassin, Christos Kattamis

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Acta bio-medica : Atenei Parmensis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 5 countries.

Vincenzo De SanctisQuisisana Hospital, Ferrara. vdesanctis@libero.it.
Shahina DaarDepartment of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Sultanate of Oman. sf.daar@gmail.com.
Ashraf T SolimanDepartment of Pediatrics, Hamad General Hospital, Doha, Qatar. atsoliman56@gmail.com.
Ploutarchos TzoulisDepartment of Diabetes and Endocrinology, Whittington Hospital, University College London, London, UK. ptzoulis@yahoo.co.uk.
Mohamed YassinHematology Section, Medical Oncology, National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar. yassinmoha@gmail.com.
Christos KattamisΤhalassemia Unit, First Department of Paediatrics, National Kapodistrian University of Athens 11527, Greece. christos.kattamis@gmail.com.
Arcispedale Sant'Anna · ITHamad General Hospital · QANational and Kapodistrian University of Athens · GRNational Center for Cancer Care and Research · QASultan Qaboos University · OMWhittington Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the rising prevalence of obesity worldwide, it is becoming imperative to detect disturbed glucose metabolism as early as possible in order to prevent type 2 diabetes (T2D) development. STUDY

designThe present retrospective observational study aimed to evaluate the relationship between BMI and glucose metabolism, insulin secretion and sensitivity indices, derived from glucose tolerance test (OGTT), in β -TM female patients who were overweight (BMI 25-29.9 kg/m2) and follow its outcome over time. SUBJECTS AND

methodsEleven overweight and 11 females with ideal weight and β -TM, matched for age, were recruited. OGTT was undertaken and different indices for β-cell function, insulin sensitivity and insulin secretion were calculated.

resultsAt first evaluation, 7 of 11 overweight β -TM patients (63.6%) and 3 of 11 normal weight β-TM patients (27.2%) had glucose dysregulation (GD) during OGTT. Overweight patients with β-TM had increased HOMA-IR and QUICKI indices associated with decreased Matsuda WBISI index. The mean ± SD duration of follow-up was 4.5 ± 1.2 years. At last observation, 2/11 overweight patients had developed T2D (18.1%). In patients with normal weight, GD increased from 3/11 (27.2%) to 5/11 (45.4%), but none developed T2DM. The difference between SF at first and last observation (1,220 ± 702 vs.1,091 ± 454 ng/mL; P: 0.61) was not significant.

conclusionOverweight seems to be an additional risk factor for the development of GD in β-TM patients. This is particularly important in clinical practice, due to the lack of appropriate guidelines dedicated to this group of patients.

Indexed as

beta-ThalassemiaDiabetes Mellitus, Type 2Insulin ResistanceBlood GlucoseFemaleGlucoseHomeostasisHumansOverweightRetrospective StudiesWeight GainYoung AdultBlood GlucoseGlucose

Identifiers

PMID37850764
PMCPMC10644933
OpenAlexW4387728709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.